1-165-Erythropoietin (human JR-013), glycoform κ (9CI)(879555-13-2)
- Name: 1-165-Erythropoietin (human JR-013), glycoform κ (9CI)
- Synonyms:Epoetin kappa;
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:879555-13-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 893428-72-3/4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)
- 390800-88-1/2-Pyrazinecarboxamide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-methylbutylidene]imino[(1S)-2-oxo-1-(phenylmethyl)-2,1-ethanediyl]]]tris-
- 39570-96-2/L-Isoleucine, N-[N-[N-[(4-methylphenylsulfonyl]-S-(phenylmethyl)-L-cysteinyl]-L-tyrosyl]-, hydrazide (9CI)
- 149456-98-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-methoxy-2-phenoxyphenyl]-
- 149457-03-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
- 1198178-65-2/Cyclopropanecarboxamide, 1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (1R,2R)-, 4-methylbenzenesulfonate (1:1)
- 120788-03-6/Ethanethioic acid, S-(tetrahydro-1-oxido-3-thienyl) ester, (1R-cis)- (9CI)
- 123664-84-6/Methanesulfonamide, N-(5-methoxy-2-phenoxyphenyl)-
- 1001859-46-6/RiferMinogene PecaplasMid
- 665058-78-6/DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-T-sp-C-G-sp-T-sp-T) (9CI)
- 67978-05-6/4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)
- 923591-06-4/3H,5H-2,23:5,8-Dimethano-1H-4,13,2,8,11-benzodioxatriazacycloheneicosine-7-carboxylic acid, 10-(1,1-dimethylethyl)-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-15,15-dimethyl-3,9,12-trioxo-, methyl ester, (5R,7S,10S)-
- 947408-94-8/1,2-Benzisoxazol-3(2H)-one, 6-methyl-2-(triphenylmethyl)-
- 947408-95-9/1,2-Benzisoxazol-3(2H)-one, 6-(bromomethyl)-2-(triphenylmethyl)-
- 947409-01-0/Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[[2,3-dihydro-3-oxo-2-(triphenylmethyl)-1,2-benzisoxazol-6-yl]methoxy]-, methyl ester
- 913695-00-8/1H-Benzimidazole, 2-[[[4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1), (+)-
- 472960-22-8/Serum albumin (human) fusion protein with interferon α2 (human)
- 762263-14-9/1-165-Erythropoietin (human), glycoform θ
- 869858-13-9/Thrombin (synthetic human) (9CI)
- 879555-13-2/1-165-Erythropoietin (human JR-013), glycoform κ (9CI)
- 897936-89-9/Blood-coagulation factor VII [158-aspartic acid,296-valine,298-glutamine] (synthetic human)
- 909110-25-4/β-Lymphotoxin receptor (human extracellular domain-containing fragment) fusion protein with immunoglobulin G1 (human γ1-chain Fc fragment)
- 158671-29-5/Benzamide, N,2-dihydroxy-4-methyl-
- 268544-50-9/2-[(2-Methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid 1,1-dimethylethyl ester
- 855425-38-6/Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-
- 910656-45-0/Butanoic acid, 2-hydroxy-2-(trifluoromethyl)-, hydrazide
- 579494-66-9/Benzeneacetic acid, 4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxy-, propyl ester
- 610300-00-0/Octanoic acid, 3-amino-5-methyl-, hydrochloride (1:1), (3S,5R)-
- 702686-97-3/Benzenepropanoic acid, 3-[(2R)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]-4,5-difluoro-, ethyl ester, hydrochloride (1:1)
- 945717-05-5/Benzeneethanamine, 4-chloro-3-ethyl-, hydrochloride (1:1)